Medically reviewed by Steffini Stalos, DO Bladder cancer occurs when cancerous cells form in the tissues of the bladder, the hollow organ in your abdomen that stores urine. The bladder has several ...
Bladder cancer can be curable, and the likelihood of cure is higher if it is diagnosed at an early stage. Without treatment, bladder cancer does not go away on its own, and treatment is associated ...
Up to 40% of patients with bladder cancer have renal impairment ... discuss therapeutic strategies for patients with advanced TCC and renal impairment. It should be stressed that the ...
Advanced transitional-cell carcinoma of the bladder is the most common cancer of the urinary tract, with a high mortality rate. Cisplatin-based chemotherapy has demonstrated prolonged survival of ...
Bladder cancer develops when abnormal cells grow uncontrollably in the tissue layers of the bladder. While often thought of as a single condition, bladder cancer exists in multiple forms ...
Bladder cancer is a cancer that forms in tissues of the bladder. Most bladder cancers are transitional cell carcinomas (cancer that begins in cells that normally make up the inner lining of the ...
Bladder cancer is the most common malignant tumor of the urinary system. We investigated the clinical implications of cell lineages in bladder cancer by integrating single-cell and bulk transcriptome ...
2 Department of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA 3 Department of General Internal Medicine/Palliative Medicine, Mayo Clinic, Rochester, Minnesota, USA Transitional cell ...
Researchers discover novel targets for bladder cancer therapeutics and demonstrate that a new combination of existing drugs, including statins, blocks tumor growth in mice. Like all cancers ...
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...
A recent study finds that sequential gemcitabine/docetaxel treatment offers better outcomes than additional BCG therapy for ...